Skip to main content
MicrobiologyOpen logoLink to MicrobiologyOpen
. 2018 Jul 5;8(4):e00684. doi: 10.1002/mbo3.684

Expression of Francisella pathogenicity island protein intracellular growth locus E (IglE) in mammalian cells is involved in intracellular trafficking, possibly through microtubule organizing center

Takashi Shimizu 1,2, Shiho Otonari 2, Jin Suzuki 1, Akihiko Uda 3, Kenta Watanabe 1,2, Masahisa Watarai 1,2,
PMCID: PMC6460260  PMID: 29978561

Abstract

Francisella tularensis is the causative agent of the infectious disease tularemia and is designated a category A bioterrorism agent. The type VI secretion system encoded by the Francisella pathogenicity island (FPI) is necessary for intracellular growth; however, the functions of FPI proteins are largely unknown. In this study, we found that the FPI protein intracellular growth locus E (IglE) showed a unique localization pattern compared to other FPI proteins. Deleting iglE from Francisella tularensis subsp. novicida (F. novicida) decreased intracellular growth. Immunoprecipitation and pull‐down assays revealed that IglE was associated with β‐tubulin. Additionally, GFP‐fused IglE colocalized with microtubule organizing centers (MTOCs) in 293T cells. The iglE deletion mutant was transferred with dynein toward MTOCs and packed into lysosome‐localizing areas. Conversely, the wild‐type F. novicida exhibited intracellular growth distant from MTOCs. In addition, IglE expressed in 293T cells colocalized with dynein. These results suggest that IglE helps to prevent dynein‐ and MTOC‐mediated intracellular trafficking in host cells to inhibit the transport of F. novicida toward lysosomes.

Keywords: Francisella, MTOCs, type VI secretion system

1. INTRODUCTION

Effector proteins are virulence factors secreted by various pathogenic bacteria. Effector proteins hijack intracellular signaling and trafficking and the cytoskeleton, changing the intracellular environment to promote bacterial replication and survival (Mattoo, Lee, & Dixon, 2007). These effectors are secreted by various secretion systems, which are classified into nine types (types I–IX) (Desvaux, Hébraud, Talon, & Henderson, 2009; Nakayama, 2015). Because they play a critical role in virulence, effector proteins, and secretion systems are attractive targets for the treatment of infectious diseases (Charro & Mota, 2015). Of the nine secretion systems, only the type VI secretion system (T6SS) is present in members of the genus Francisella (Bröms, Sjöstedt, & Lavander, 2010). Although several Francisella effector proteins are reportedly important for its intracellular growth and virulence (Bröms, Meyer, Sun, Lavander, & Sjöstedt, 2012; Eshraghi et al., 2016), the molecular mechanisms underlying the functions of these proteins are poorly understood.

Francisella tularensis subsp. tularensis (F. tularensis) is a gram‐negative, facultative intracellular bacterium that causes the zoonotic disease tularemia (Decors et al., 2011; Ellis, Oyston, Green, & Titball, 2002), and it is classified as a category A bioterrorism agent (Maurin, 2015). The vector‐borne transmission of F. tularensis to mammalian hosts precedes the development of tularemia (Petersen, Mead, & Schriefer, 2009; Suzuki, Uda, Watanabe, Shimizu, & Watarai, 2016; Suzuki, Hashino, et al., 2016). F. tularensis subsp. novicida (F. novicida) is closely related to F. tularensis and is also a facultative intracellular pathogen that replicates within macrophages (Anthony, Burke, & Nano, 1991). Although F. novicida exhibits low virulence in humans, it is thought to share considerable homology with F. tularensis and thus serves as a practicable surrogate for studies (Kingry & Petersen, 2014).

Francisella are ingested through the pseudopod loops of macrophages and taken up into spacious vacuoles possessing endosomal markers (Clemens, Lee, & Horwitz, 2004, 2005). Subsequently, the bacteria escape from the phagosomes and replicate in the cytosol (Golovliov, Baranov, Krocova, Kovarova, & Sjöstedt, 2003). In the late stage of infection, the bacteria reenter the autophagosomes (Checroun, Wehrly, Fischer, Hayes, & Celli, 2006). They acquire amino acids from degraded proteins and replicate there (Checroun et al., 2006). Replication‐deficient or damaged cytosolic bacteria are caught by lysosomal‐associated membrane protein 1 (LAMP‐1)‐positive autophagosomes, termed Francisella‐containing vacuoles and are degraded by the ubiquitin‐SQSTM1‐LC3 pathway (Chong et al., 2012).

The Francisella pathogenicity island (FPI) is a genetic element that is critical for the intracellular growth of Francisella (Barker et al., 2009; Nano et al., 2004). F. tularensis possesses two copies of the FPI, whereas F. novicida contains a single copy. The FPI is a cluster of approximately 30 kb in length, coding 16–19 open reading frames. Although the sequence homology is limited, several FPI genes are thought to encode a T6SS (Bröms et al., 2010; Clemens, Ge, Lee, Horwitz, & Zhou, 2015), one of the secretion systems recently discovered in gram‐negative bacteria (Cianfanelli, Monlezun, & Coulthurst, 2016; Ho, Dong, & Mekalanos, 2014; Mougous et al., 2006; Pukatzki et al., 2006). The T6SS injects protein effectors into host cells or neighboring bacteria (Hachani, Wood, & Filloux, 2016) through a contractile needle similar to a T4‐like bacteriophage tail (Aksyuk et al., 2009). The T6SS is critical for quorum sensing, stress responses, biofilm formation, symbiosis, virulence, intramacrophage growth, and antibacterial activities of pathogenic bacteria such as Burkholderia mallei, Pseudomonas aeruginosa, Vibrio cholera, and Campylobacter jejuni (Chen, Zou, She, & Wu, 2015; Lertpiriyapong et al., 2012; Pukatzki et al., 2006; Schwarz et al., 2010). However, the detailed functions of FPI proteins in host cells have yet to be described.

In this study, we carried out an expression analysis of FPI proteins and found that the F. novicida intracellular growth locus E (IglE) shows unique localization and is associated with microtubule‐organizing centers (MTOCs) to modulate membrane trafficking for the intracellular growth of the bacterium.

2. MATERIALS AND METHODS

2.1. Bacterial strains and culture conditions

F. novicida U112 was obtained from the Pathogenic Microorganism Genetic Resource Stock Center (Gifu University). F. novicida was cultured aerobically at 37°C in a chemically defined medium (CDM) (Nagle, Anderson, & Gary, 1960) or in a brain–heart infusion broth (Becton, Dickinson and Company, Franklin Lakes, NJ) supplemented with cysteine (BHIc) (Mc Gann et al., 2010) containing 1.5% agar (Wako Laboratory Chemicals, Osaka, Japan).

2.2. Cell culture

THP‐1 cells (human monocytic cell line) were grown in RPMI 1640 medium (Sigma‐Aldrich, St. Louis, MO) supplemented with 10% heat‐inactivated fetal bovine serum (FBS) at 37°C in an atmosphere containing 5% CO2; 293T cells (human kidney cell line) were grown in DMEM medium (Sigma‐Aldrich) supplemented with 10% heat‐inactivated FBS at 37°C in an atmosphere containing 5% CO2.

2.3. Plasmid construction, transformation, and transfection

Table S1 shows the primer sets and templates used to construct plasmids used in this study. PCR was carried out using KOD‐Plus‐Neo polymerase (Toyobo, Osaka, Japan), and ligation was performed with the Ligation High Ver. 2 kit (Toyobo) or the In‐Fusion HD Cloning Kit (Takara Bio, Otsu, Japan). Plasmids were transformed into F. novicida by cryotransformation (Pavlov, Mokrievich, & Volkovoy, 1996). Briefly, bacterial cells were suspended in transfer buffer (0.2 M MgSO4, 0.1 M Tris acetate [pH 7.5]) with 1 μg of plasmid DNA. The bacterial cells were frozen in liquid nitrogen, thawed at room temperature, and then cultured in CDM. Then, bacterial cells were collected and cultured on BHIc plates containing 50 μg/ml kanamycin or 2.5 μg/ml chloramphenicol. Plasmids were transferred into cell lines with FuGENE HD (Promega, Madison, WI) according to the instruction manual.

2.4. Construction of F. tularensis iglE and dotU mutants

The ΔdotU mutants of F. novicida were generated by group II intron insertion using the TargeTron Gene Knockout System (Sigma‐Aldrich) modified for Francisella species (Rodriguez, Yu, Davis, Arulanandam, & Klose, 2008), as described previously (Uda et al., 2014). Briefly, 2 μg of each pKEK‐DotU was transformed, and bacterial cells were precultured in CDM at 30°C for 6 hr. Then, the cells were collected and cultured on BHIc plates containing 50 μg/ml kanamycin at 30°C. Mutagenesis was confirmed using PCR to detect the 915‐bp insertion. To remove the plasmids, mutants cells were further cultured on BHIc plates without antibiotics at 37°C.

The ΔiglE mutant was constructed by homologous recombination. To make the suicide vector pFRSU, the promoter region of sacB and antibiotic‐resistance marker of pSR47s (Merriam, Mathur, Maxfield‐Boumil, & Isberg, 1997) were replaced with the bfr promoter of pNVU1 (Uda et al., 2014) and the kanamycin‐resistance gene kanR from pKEK1170 (Rodriguez et al., 2008), respectively. The upstream and downstream regions of iglE (1.5 kb each) were cloned into the SalI site of pFRSU to make pFRSU‐IglE. One microgram of pFRSU‐IglE was transformed into F. novicida, and the cells were cultured on BHIc plates containing 50 μg/ml kanamycin. Isolated bacteria were cultured in CDM without antibiotics for 6 hr and then plated on BHIc plates containing 5% sucrose. The deletion of the iglE gene was confirmed by PCR.

2.5. GFP‐, mCherry‐, and IglE‐expressing F. novicida strains

The gfp gene with the Shine‐Dalgarno (SD) sequence was recloned from pGreenTIR (Miller & Lindow, 1997) into pNVU1 to make pNVU‐GFP. Then, the gfp gene with the bfr promoter of pNVU‐GFP was cloned into pOM5 (Pomerantsev, Obuchi, & Ohara, 2001) to make pOM5‐GFP. To make pOM5‐mCherry, the gfp gene of pOM5‐GFP was exchanged with mCherry gene from pmCherry‐C1 (Takara Bio). Chromosomal iglE from F. novicida genome was cloned into pNVU‐1 to make pNVU‐IglE. Then, the iglE gene with the bfr promoter from pNVU‐IglE was cloned into pOM5 to make pOM5‐IglE. To make the GFP and IglE double‐expressing plasmid pOM5‐GFP‐IglE, the iglE gene from pOM5‐IglE was inserted downstream of the gfp gene in pOM5‐GFP. pOM5‐GFP, pOM5‐mCherry, pOM5‐IglE, and pOM5‐GFP‐IglE were transformed into the wild‐type or ΔiglE mutant of F. novicida by cryo‐transformation.

2.6. IglE expression assay

The iglE gene from F. tularensis subsp. tularensis SCHU P9 (Uda et al., 2014) was cloned into pAcGFP‐C1 and pmCherry‐C1 to make pAcGFP‐C1‐IglE and pmCherry‐C1‐IglE. pAcGFP‐C1‐IglE or pmCherry‐C1‐IglE were transfected into 293T cells, using FuGENE HD. After 48 hr of incubation, the cells were treated and observed with confocal microscopy.

2.7. Immunoblotting

To generate an antiserum against IglE, rabbits were immunized with the C+TGKNEFPLDKDIKD peptide. The peptide and antiserum were prepared by Eurofine Genetics (Tokyo, Japan). F. novicida was cultured in CDM containing 5% KCl to an OD595 of 0.25. The culture supernatants were desalted to remove KCl with Amicon Ultra filters (Merck Millipore, Billerica, MA) and concentrated fivefold. Samples were mixed with SDS sample buffer (Thermo Fisher Scientific, Waltham, MA). Fifteen microliters of sample was loaded onto a NuPAGE Novex 4%–12% Bis‐Tris Gel (Thermo Fisher Scientific) and separated by SDS‐PAGE. Separated proteins were transferred onto a polyvinyl difluoride (PVDF) membrane (Merck Millipore). The membrane was treated with anti‐IglE antiserum (1:100) or anti‐PdpC antibody (Chong et al., 2008; Uda et al., 2014), a generous gift from Dr. J. Celli, followed by the treatment with HRP‐conjugated anti‐rabbit IgG (ab6717, 1:20,000; Abcam, Cambridge, UK). Proteins were detected with the ECL Prime Western Blotting System (GE Healthcare, Buckinghamshire, UK) and the LAS‐4000 mini Imaging System (Fujifilm Life Science, Tokyo, Japan).

2.8. Intracellular growth assay

THP‐1 cells (4 × 105 cells/well) were preincubated in a 48‐well tissue culture plate with 100 nM of phorbol myristate acetate (PMA) for 48 hr. F. novicida strains were added at a multiplicity of infection of 1. These plates were centrifuged for 10 min at 300× g and incubated for 30 min at 37°C. Then, THP‐1 cells were washed twice with RPMI1640 medium, and extracellular bacteria were killed with a 60‐min gentamicin (50 μg/ml) treatment. To measure the intracellular growth of F. novicida, the THP‐1 cells were incubated in fresh medium at 37°C for the indicated time, washed three times with phosphate‐buffered saline (PBS), and then lysed with 0.1% Triton X‐100 in CDM. Colony‐forming units were determined by serial dilution on BHIc plates.

2.9. Fluorescence microscopy

293T cells (1 × 105 cells/well) were transfected with 250 ng/well of pAcGFP‐C1‐IglE, pmCherry‐C1‐IglE, pAcGFP‐IglE‐N, or pAcGFP‐IglE‐C on 12‐mm glass coverslips (Matsunami Glass Industries, Ltd., Osaka, Japan). The cells were incubated for 48 hr and treated for microscopy. THP‐1 cells (4 × 105 cells/well) were preincubated in a 48‐well tissue culture plate with 100 nM PMA for 48 hr on 12‐mm glass coverslips. F. novicida strains were infected similarly. After incubation for the indicated times, THP‐1 cells were treated for microscopy.

For MTOC staining, the cells were fixed with 4% paraformaldehyde at room temperature for 30 min and permeabilized with 0.1% TritonX‐100 in PBS. The cells were treated with anti‐pericentrin antibody (ab4448, 1:100; Abcam) and then stained with Alexa555‐conjugated anti‐rabbit IgG or FITC‐conjugated anti‐rabbit IgG (1:1,000). Fluorescent images were obtained with a FluoView. For LAMP‐1 staining, cells were fixed with the PLP Solution Set (Wako Laboratory Chemicals) containing 5% sucrose for 1 hr at 37°C and permeabilized with cold methanol for 10 s. The cells were treated with anti‐LAMP‐1 antibody (ab25245, 1:100; Abcam) and were stained with TRITC‐conjugated anti‐rat IgG (ab7094, 1:1,000; Abcam). To visualize endosomes, 100 μg/ml of Texas Red‐labeled dextran (molecular weight: 70,000; Thermo Fisher Scientific) was added to the cells 6 hr after transfection. For dynein staining, cells were fixed with 4% paraformaldehyde at room temperature for 30 min and permeabilized with 0.1% TritonX‐100 in PBS. Then, cells were treated with anti‐dynein antibody (ab23905, 1:20; Abcam) and stained with FITC‐conjugated anti‐mouse IgG (1:1,000). The FluoView FV100 confocal laser‐scanning microscope (Olympus, Tokyo, Japan) was used to obtain fluorescent images.

2.10. Immunoprecipitation assay

For the immunoprecipitation assays, 293T cells (1 × 106 cells/well) in a six‐well plate were transfected with 2 μg/well of pAcGFP‐C1‐IglE, using FuGENE HD. After 48 hr of incubation, GFP‐fused proteins were collected, using the GFP‐Trap (ChromoTek GmbH, Planegg‐Martinsried, Germany) according to the instruction manual. Samples were suspended in SDS sample buffer and heated at 70°C for 15 min. Fifteen microliters of sample was loaded onto a NuPAGE Novex 4%–12% Bis‐Tris Gel, and the proteins that co‐precipitated with IglE‐GFP were separated by SDS‐PAGE followed by staining with Quick‐CBB PLUS (Wako Laboratory Chemicals). Peptide mass fingerprinting was performed according to the method of Yoshino et al. (Yoshino, Oshiro, Tokunaga, & Yonezawa, 2004). Briefly, the CBB‐stained bands obtained from SDS‐PAGE were excised and sliced into small strips. To remove the CBB, the strips were incubated in 50% methanol and 5% acetic acid for 1 hr and washed twice with water. The strips were dehydrated by incubation with 100% acetonitrile. To alkylate the proteins, the strips were incubated at 60°C for 1 hr with 10 mM dithiothreitol in 100 mM ammonium hydrogen carbonate followed by treatment at room temperature for 30 min with 55 mM iodoacetamide (Nacalai Tesque, Kyoto, Japan) in 100 mM ammonium hydrogen carbonate. In‐gel trypsin digestion was performed by incubating a gel with 10 μg/ml trypsin (Promega). The digested peptides were eluted using 5% formic acid (Wako Laboratory Chemicals). The peptides were desalted with ZipTip C18 Pipette Tips (Merck Millipore), spotted onto sample plates, and mounted with saturated α‐cyano‐4‐hydroxycinnamic acid (Nacalai Tesque) in 50% acetonitrile and 0.1% trifluoroacetic acid. An Autoflex mass spectrometer (Bruker Daltonics, Billerica, MA, USA) was used to measure the molecular weights of peptides. The reference database was searched by MASCOT software (Science Matrix, London, UK).

2.11. Pull‐down assay

The iglE gene from F. tularensis subsp. tularensis SCHU P9 was cloned into pCMV‐Myc‐N to make pCMV‐Myc‐N‐IglE. The β‐tubulin gene (TUBB) was cloned from THP‐1 cDNA into pCMV‐HA‐N to make pCMV‐HA‐N‐β‐tubulin. 293T cells (1 × 106 cells/well) in a 6‐well plate were transfected with 2 μg/well of pCMV‐Myc‐N‐IglE or pCMV‐HA‐N‐β‐tubulin using FuGENE HD. After 48 hr of incubation, cells were lysed with 3 ml of lysis buffer (5 mM EDTA, 0.5% Triton X‐100, in PBS) containing protease inhibitor cocktail (Nacalai Tesque). Twenty microliters of protein G agarose beads (Cell Signaling Technology, Danvers, MA) was added to 1.2 ml of lysate and incubated for 1 hr at 4°C. Protein G agarose beads were removed, and 25 μl of protein G agarose beads and 2 μg of HA‐Tag polyclonal antibody (Takara Bio) were added. The lysate was incubated overnight at 4°C. Beads were collected by centrifugation, washed 5 times with PBS, and resuspended in 25 μl of SDS sample buffer (Thermo Fisher Scientific). Samples were heated at 70°C for 15 min and the beads were removed. Fifteen microliters of each supernatant was loaded on to a NuPAGE Novex 12% Bis‐Tris Gel and separated by SDS‐PAGE. The separated proteins were transferred to a PVDF membrane. The membrane was treated with 2 μg/ml of c‐Myc monoclonal antibody (Takara Bio) and HRP‐conjugated anti‐mouse IgG (1:10,000). Proteins were detected with the ECL Prime Western Blotting System (GE Healthcare) and the LAS‐4000 mini Imaging System.

2.12. Statistical analysis

One‐way analysis of variance was used to compare the results expressed as the means and standard deviations. Differences between the groups were determined by multiple comparisons using the Bonferroni/Dunnett method. The differences were considered significant at p values < 0.01.

3. RESULTS

3.1. IglE shows unique localization

Among the FPI proteins, 8 of them (PdpA, IglE, VgrG, IglF, IglI, IglJ, PdpE, and IglC) are considered to be secreted into the host cytosol (Bröms et al., 2012). To elucidate the function of FPI proteins secreted by F. novicida, we performed a comprehensive expression analysis of these eight FPI proteins. We assayed the localization of these proteins in host cells by expressing GFP fused to FPI proteins in 293T cells (Figure S1). Among the 8 FPI proteins, only IglE showed unique localization—large foci near the nucleus and dot foci (Figure 1a). The fractions of cells containing large or dot foci were 46.7 ± 4.2% and 86.0 ± 5.3%, respectively (Figure 1b).

Figure 1.

Figure 1

Intracellular growth locus E (IglE) shows unique localization. (a) 293T cells were transfected with pAcGFP‐C1‐IglE and incubated for 48 hr. The white arrow and arrowhead indicate large and dot foci, respectively. Scale bar: 20 μm. (b) The numbers of cells with large and dot IglE foci were calculated for 50 IglE‐expressing cells

3.2. Intracellular replication of F. novicida depends on IglE secretion

We focused on IglE as an effector protein and assessed its characteristics because of its unique localization. First, we constructed an iglE deletion (ΔiglE) mutant of F. novicida by homologous recombination. This mutation decreased the intracellular growth of F. novicida in THP‐1 cells, but complementation with wild‐type iglE restored the intracellular growth (Figure 2a). These results indicated that IglE was important for intracellular growth. To examine whether IglE protein was secreted into the culture medium, we cultured F. novicida in medium containing high concentrations of potassium chloride to mimic the host intracellular environment. Although the secretion of PdpC, an FPI protein, was not observed (Figure S2), we observed IglE secretion in the wild‐type and IglE overexpressing strains. However, the amount of IglE secreted from the wild‐type bacteria was limited. Importantly, the secretion was not observed in the dotU deletion mutant (ΔdotU, a gene encoding part of the T6SS apparatus), and the secretion decreased in the ΔdotU mutant that overexpressed IglE (Figures 2b and S2a).

Figure 2.

Figure 2

Intracellular replication of Francisella novicida is dependent on intracellular growth locus E (IglE) secretion. (a) THP‐1 cells were infected with F. novicida at multiplicity of infection = 1 and treated with 50 μg/ml of gentamicin. Cells were disrupted with 0.1% TritonX‐100 and plated on brain heart infusion broth supplemented with cysteine (BHIc) agar at indicated times postinfection. (b) F. novicida was cultured in BHIc medium‐containing 5% KCl. Bacterial cells were collected by centrifugation, and the supernatants were filtered and desalted with an ultrafiltration membrane. The presence of IglE in whole cells and in the culture supernatants was detected by immunoblotting

3.3. IglE is associated with β‐tubulin and MTOCs

To identify IglE‐binding proteins, GFP‐fused IglE was expressed in 293T cells, and GFP protein was precipitated with GFP‐binding protein‐conjugated agarose beads. The co‐precipitated proteins were separated by SDS‐PAGE. A protein of approximately 50 kDa was co‐precipitated with GFP‐fused IglE (Figure 3a). We identified this 50 kDa protein by matrix‐assisted laser‐desorption ionization/time‐of‐flight mass spectrometry as β‐tubulin. To confirm the interaction between IglE and β‐tubulin, a pull‐down assay was conducted. HA‐tagged β‐tubulin and Myc‐tagged IglE were expressed in 293T cells and precipitated with anti‐HA antibody using protein G agarose beads. Co‐precipitated Myc‐tagged IglE was detected by immunoblotting with an anti‐Myc antibody. Consequently, Myc‐tagged IglE was co‐precipitated with HA‐tagged β‐tubulin (Figure 3b). To determine whether IglE localized with β‐tubulin or microtubules in vivo, GFP‐fused IglE was expressed in 293T cells, and the cells were stained with an anti‐β‐tubulin antibody. Unexpectedly, we did not observe colocalization of β‐tubulin and IglE (Figure 3c).

Figure 3.

Figure 3

Intracellular growth locus E (IglE) is associated with β‐tubulin and microtubule organizing centers (MTOCs). (a) 293T cells were transfected with pAcGFP‐C1‐IglE and incubated for 48 hr. The cells were disrupted, and IglE‐GFP protein was precipitated with the GFP‐Trap. Co‐precipitated proteins were separated by SDS‐PAGE and extracted from the gel. The extracted protein was examined with matrix‐assisted laser‐desorption ionization/time‐of‐flight mass spectrometry. (b) Binding of IglE and β‐tubulin was confirmed with a pull‐down assay. 293T cells were transfected with pCMV‐HA‐N‐β‐tubulin and pCMV‐Myc‐N‐IglE. β‐tubulin was precipitated by anti‐HA antibody‐conjugated agarose beads and separated by SDS‐PAGE. Co‐precipitated IglE‐Myc protein was detected by immunoblotting for anti‐Myc antibody (IB: Myc). (c) 293T cells were transfected with pAcGFP‐C1‐IglE and incubated for 48 hr. β‐tubulin was stained using Alexa555‐conjugated anti‐β‐tubulin antibody. Scale bar: 20 μm. (d) 293T cells were transfected with pAcGFP‐C1‐IglE and incubated for 48 hr. MTOCs were stained using anti‐pericentrin antibody and Alexa555‐conjugated anti‐rabbit antibody. To observe the detailed localization of GFP‐fused IglE, the sensitivity of detection for GFP was decreased compared to the experiment in Figure 1a. Scale bar: 20 μm. (e) THP‐1 cells were infected with Francisella novicida harboring pOM5‐GFP at multiplicity of infection = 1 and treated with 50 μg/ml of gentamicin. At 24 hr postinfection, the cells were treated with anti‐pericentrin antibody and stained with Alexa555‐conjugated anti‐rabbit IgG. Scale bar: 40 μm. (f) The number of cells with MTOCs surrounded by F. novicida was calculated for F. novicida‐infected cells. *< 0.01

Because β‐tubulin is a component of MTOCs (Conduit, Wainman, & Raff, 2015), we examined the localization of IglE and MTOCs. GFP‐fused IglE was expressed in 293T cells, and MTOCs were stained with an antibody against the MTOC marker pericentrin. The localization of MTOCs overlapped with the large foci of IglE (Figure 3d). To investigate the relationship between MTOCs and F. novicida infection, THP‐1 cells were infected with the wild‐type and ΔiglE F. novicida, and we assayed the localization of MTOCs (Figure 3e). When the host cells were infected with the wild‐type strain, bacteria were not observed around MTOCs. In contrast, ΔiglE mutants accumulated around MTOCs. In F. novicida‐infected cells, 93.8 ± 2.5% of MTOCs were surrounded by ΔiglE mutants, whereas only approximately 31.8 ± 4.1% and 38.1 ± 2.9% of MTOCs were localized with the wild‐type and complemented strains, respectively (Figure 3f). These results suggest that IglE interacts with MTOCs in host cells and inhibits the intracellular trafficking of F. novicida toward MTOCs.

3.4. IglE disturbs membrane trafficking through MTOCs

In general, phagosomes are transported toward MTOCs on microtubules. Lysosomes are also present around MTOC and fuse with phagosomes (Blocker, Griffiths, Olivo, Hyman, & Severin, 1998). To examine the influence of IglE on this step, we infected THP‐1 cells with F. novicida and used an anti‐LAMP‐1 antibody to visualize the location of lysosomes. After infection, ΔiglE mutants localized within the LAMP‐1‐positive area, whereas the wild‐type and complemented strains grew in areas distant from the LAMP‐1‐positive area (Figure 4a). The fractions of THP‐1 cells containing F. novicida distant from a LAMP‐1‐positive area were 94.4 ± 1.9% for cells infected with the wild‐type bacteria and 97.7 ± 1.9% for cells infected with iglE‐complemented bacteria, whereas cells containing ΔiglE mutants distant from the LAMP‐1‐positive area numbered 5.6 ± 1.9% only (Figure 4b). Although most of the wild‐type and complemented bacteria did not localize to the LAMP‐1 positive area, some bacteria did accumulate in the LAMP‐1‐positive area (Figure 4a). Indeed, 46.7 ± 10.0% and 63.3 ± 6.7% of THP‐1 cells infected with the wild‐type or complemented bacteria contained bacteria within the LAMP‐1 positive area, respectively (Figure 4c).

Figure 4.

Figure 4

Intracellular growth locus E (IglE) disturbs membrane trafficking through microtubule organizing center. (a) THP‐1 cells were infected with Francisella novicida harboring pOM5‐GFP at multiplicity of infection = 1 and treated with 50 μg/ml of gentamicin. At 24 hr after infection, cells were treated with anti‐lysosomal‐associated membrane protein 1 (LAMP‐1) antibody and stained with TRITC‐conjugated anti‐rat IgG. Scale bar: 40 μm. (b) The number of cells containing F. novicida outside the LAMP‐1‐positive area was calculated for F. novicida infected cells. *< 0.01. (c) The number of cells containing F. novicida colocalized to the LAMP‐1‐positive area was calculated for F. novicida‐infected cells. *< 0.01. (d) 293T cells were transfected with pAcGFP‐C1‐IglE in the presence of dextran‐TR, and incubated for 48 hr. The white arrow indicates aggregated dextran. Scale bar: 20 μm. (e) The number of cells with aggregated dextran was calculated for cells with large IglE foci. *< 0.01

To elucidate the effect of IglE on membrane trafficking, GFP‐fused IglE was expressed in 293T cells, and these cells were incubated with Texas Red‐labeled dextran. After 48 hr of incubation, the ingested dextran particles were distributed uniformly throughout the cytosol. However, in IglE‐expressing cells, dextran particles were not ingested (Figure 4d) or nonuniformly distributed and aggregated on one side (Figure 4d, white arrow). In cells with large foci near the nucleus, dextran particles were aggregated or not ingested in 65.6 ± 8.6% of cells (Figure 4e). These results suggest that IglE disturbs membrane trafficking in host cells by interacting with MTOCs, allowing F. novicida to escape from fusion with lysosomes.

3.5. IglE inhibits dynein‐based membrane trafficking

Because the minus‐end of microtubules is located near the MTOC, IglE may inhibit membrane trafficking toward the minus‐end of microtubules. To confirm this hypothesis, we assayed the localization of the motor protein dynein, which moves toward the minus‐end of microtubules. In 293T cells‐expressing mCherry‐fused IglE, dynein was localized to the tips of cells and colocalized with the dot foci of IglE (Figure 5a). Among IglE‐expressing cells, 78.3 ± 8.8% of cells contained dynein colocalized with IglE (Figure 5b). In 293T cells‐containing mCherry‐fused IglE, IglE also colocalized with pericentrin (Figure 5a). In 39.4 ± 8.4% of IglE‐expressing cells, IglE colocalized with pericentrin (Figure 5b). In F. novicida‐infected THP‐1 cells, most wild‐type bacteria did not colocalize with dynein (Figure 5c), whereas in THP‐1 cells infected with the ΔiglE mutant, dynein accumulated and colocalized with the bacteria (Figure 5c). Among the cells infected with the wild‐type or ΔiglE mutant, 32.2 ± 5.4% and 68.3 ± 5.0%, respectively, contained bacteria within dynein‐positive areas (Figure 5d). These results indicate that IglE inhibits the dynein‐based trafficking of F. novicida toward MTOCs.

Figure 5.

Figure 5

Intracellular growth locus E (IglE) colocalizes with dynein and disturbs dynein‐based membrane trafficking. (a) 293T cells were transfected with pmCherry‐C1‐IglE and incubated for 48 hr. Dynein was stained using anti‐dynein antibody and FITC‐conjugated anti‐mouse antibody. Fluorescent images were merged with differential interference contrast microscopy images. Microtubule organizing center (MTOC) was stained with anti‐pericentrin antibody and FITC‐conjugated anti‐rabbit IgG. Arrowheads indicate colocalization of IglE and MTOC. Scale bar: 40 μm. (b) The number of cells containing dynein or pericentrin colocalized with IglE was calculated for IglE‐expressing cells. (c) THP‐1 cells were infected with Francisella novicida harboring pOM5‐mCherry at multiplicity of infection = 1 and treated with 50 μg/ml of gentamicin. At 24 hr after infection, the cells were treated with anti‐dynein antibody and stained with FITC‐conjugated anti‐mouse IgG. Scale bar: 40 μm. (d) The number of cells containing F. novicida colocalized to the dynein‐positive area was calculated for F. novicida‐infected cells. *< 0.01

4. DISCUSSION

The molecular mechanisms underlying the actions of effector proteins from Francisella species are poorly understood. In this study, we revealed the function of the T6SS effector protein IglE, which associated with MTOCs and modulated the membrane trafficking of host cells. To identify how IglE affects the intracellular environment, we analyzed IglE‐binding proteins and found that β‐tubulin and pericentrin were associated with IglE. Pericentrin is a component of the γ‐tubulin ring complex (γ‐TuRC). The γ‐TuRC is the functional core of the MTOC and acts as a scaffold or a template for α/β‐tubulin dimers (Conduit et al., 2015). In THP‐1 cells, the ΔiglE mutant of F. novicida was transported to MTOCs, where lysosomes are located. Some bacterial effectors were reported to interact with microtubules or MTOCs and control the intracellular trafficking of bacteria. In Salmonella enterica, some T3SS effectors such as SseF or SseG interact with microtubules to form Salmonella‐induced filaments (Müller, Chikkaballi, & Hensel, 2012). In Pseudomonas aeruginosa, the T6SS effector VgrG2b associates with the γ‐TuRC, facilitating internalization of the bacterium (Sana et al., 2015). The Chlamydia trachomatis T3SS effector IPAM interacts with the MTOC protein CEP170 and controls microtubule assembly for inclusion morphogenesis (Dumoux, Menny, Delacour, & Hayward, 2015). Our findings suggest that IglE associates with MTOCs and controls membrane trafficking on microtubules. Indeed, membrane trafficking in IglE‐expressing cells was disturbed: dynein colocalized with IglE at the tips of cells, and ingested dextran particles accumulated on one side of the cells. Francisella species are ingested through phagocytosis and grow into the cytosol or in autophagosomes after they escape from phagosomes (Checroun et al., 2006; Chong et al., 2012; Clemens et al., 2004, 2005; Golovliov et al., 2003). For the maturation of phagosomes, endosomes and autophagosomes, motor‐based migration on microtubules toward the cell center, where lysosomes are located, is necessary (Blocker et al., 1998; Harrison, Bucci, Vieira, Schroer, & Grinstein, 2003; Kimura, Noda, & Yoshimori, 2008). In THP‐1 cells infected with the F. novicida ΔiglE mutant, bacteria accumulated with dynein around MTOCs where the lysosome marker LAMP‐1 was located, whereas the wild‐type bacteria were located far away from MTOCs. Together, these results imply that IglE associates with MTOCs to inhibit the trafficking of F. novicida‐containing phagosomes on microtubules and their subsequent fusion with lysosomes. This may allow F. novicida to escape from phagosomes and grow in the cytosol or in autophagosomes.

With a microscopic observation, IglE seemed to colocalize with MTOCs or dynein. Although IglE co‐precipitated with β‐tubulin, MTOC proteins such as pericentrin or dynein were not detected by the co‐precipitation assay with IglE. This may due to the abundance of β‐tubulin in cell cytosol. In addition, IglE expression in 293T cells failed to inhibit the depolymerization or repolymerization in the presence or absence of colchicine, an inhibitor of tubulin polymerization (data not shown). Therefore, the direct target of IglE is still unclear. However, IglE is expected to associate with β‐tubulin through MTOC or dynein because the colocalization of IglE and β‐tubulin was not observed with microscopy.

Several reports indicate that IglE is a bacterial lipoprotein with a signal peptide and is located at the bacterial membrane where it forms part of the T6SS apparatus (Bröms, Meyer, & Sjöstedt, 2017; Nguyen, Gilley, Zogaj, Rodriguez, & Klose, 2014; Robertson, Child, Ingle, Celli, & Norgard, 2013). In addition, we observed limited secretion of IglE into the culture medium. Thus, our results suggest that IglE may not be the so‐called effector protein. In fact, the secretion of other effectors, such as IglC, is inhibited in the ΔiglE mutant (Bröms et al., 2017). Therefore, in the case of the ΔiglE mutant, we could not rule out the possibility that its transportation to MTOCs and the inhibition of its intracellular growth were due to other effectors or a combination of IglE and other effectors. However, under our condition of IglE overexpression in host cells, IglE was associated with MTOCs and disturbed intracellular trafficking. These results at least suggest that IglE may have effector‐like functions when bacteria escape into the cytosol and IglE is exposed, or if bacteria are lysed and IglE is released into the cytosol. Because IglE had a signal peptide and was still secreted in the ΔdotU mutant that overexpressed IglE, IglE may be secreted by an unknown Sec protein‐related secretion system. Indeed, IglE is detected in the cytosol during Francisella infection (Bröms et al., 2012).

IglE could be a therapeutic target for treating Francisella infections or a biological tool for inhibiting intracellular trafficking because our results suggest that IglE affects MTOCs and modulates intracellular trafficking.

CONFLICT OF INTEREST

All contributing authors declare no conflicts of interest.

Supporting information

 

ACKNOWLEDGEMENTS

We thank Dr. Jean Celli for kindly supplying anti‐PdpC polyclonal antibody. This study was supported by JSPS KAKENHI Grant Number 15K08463. We acknowledge help with mass spectrometry measurements, which were supported by the general support team at Osaka City University funded by the Grant‐in‐Aid for Scientific Research on Innovative Area “Harmonized Supramolecular Motility Machinery and Its Diversity” (25117501) directed by Makoto Miyata.

Shimizu T, Otonari S, Suzuki J, Uda A, Watanabe K, Watarai M. Expression of Francisella pathogenicity island protein intracellular growth locus E (IglE) in mammalian cells is involved in intracellular trafficking, possibly through microtubule organizing center. MicrobiologyOpen. 2019;8:e684 10.1002/mbo3.684

REFERENCES

  1. Aksyuk, A. A. , Leiman, P. G. , Kurochkina, L. P. , Shneider, M. M. , Kostyuchenko, V. A. , Mesyanzhinov, V. V. , & Rossmann, M. G. (2009). The tail sheath structure of bacteriophage T4: A molecular machine for infecting bacteria. EMBO Journal, 28, 821–829. 10.1038/emboj.2009.36 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anthony, L. D. , Burke, R. D. , & Nano, F. E. (1991). Growth of Francisella spp. in rodent macrophages. Infection and Immunity, 59, 3291–3296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barker, J. R. , Chong, A. , Wehrly, T. D. , Yu, J. J. , Rodriguez, S. A. , Liu, J. , … Klose, K. E. (2009). The Francisella tularensis pathogenicity island encodes a secretion system that is required for phagosome escape and virulence. Molecular Microbiology, 74, 1459–1470. 10.1111/j.1365-2958.2009.06947.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blocker, A. , Griffiths, G. , Olivo, J. C. , Hyman, A. A. , & Severin, F. F. (1998). A role for microtubule dynamics in phagosome movement. Journal of Cell Science, 111(Pt. 3), 303–312. [DOI] [PubMed] [Google Scholar]
  5. Bröms, J. E. , Meyer, L. , & Sjöstedt, A. (2017). A mutagenesis‐based approach identifies amino acids in the N‐terminal part of Francisella tularensis IglE that critically control type VI system‐mediated secretion. Virulence, 8, 821–847. 10.1080/21505594.2016.1258507 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bröms, J. E. , Meyer, L. , Sun, K. , Lavander, M. , & Sjöstedt, A. (2012). Unique substrates secreted by the type VI secretion system of Francisella tularensis during intramacrophage infection. PLoS ONE, 7, e50473 10.1371/journal.pone.0050473 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bröms, J. E. , Sjöstedt, A. , & Lavander, M. (2010). The role of the Francisella tularensis pathogenicity island in type VI secretion, intracellular survival, and modulation of host cell signaling. Frontiers in Microbiology, 1, 136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Charro, N. , & Mota, L. J. (2015). Approaches targeting the type III secretion system to treat or prevent bacterial infections. Expert Opinion on Drug Discovery, 10, 373–387. 10.1517/17460441.2015.1019860 [DOI] [PubMed] [Google Scholar]
  9. Checroun, C. , Wehrly, T. D. , Fischer, E. R. , Hayes, S. F. , & Celli, J. (2006). Autophagy‐mediated reentry of Francisella tularensis into the endocytic compartment after cytoplasmic replication. Proceedings of the National Academy of Sciences of the United States of America, 103, 14578–14583. 10.1073/pnas.0601838103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chen, L. , Zou, Y. , She, P. , & Wu, Y. (2015). Composition, function, and regulation of T6SS in Pseudomonas aeruginosa . Microbiological Research, 172, 19–25. 10.1016/j.micres.2015.01.004 [DOI] [PubMed] [Google Scholar]
  11. Chong, A. , Wehrly, T. D. , Child, R. , Hansen, B. , Hwang, S. , Virgin, H. W. , & Celli, J. (2012). Cytosolic clearance of replication‐deficient mutants reveals Francisella tularensis interactions with the autophagic pathway. Autophagy, 8, 1342–1356. 10.4161/auto.20808 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chong, A. , Wehrly, T. D. , Nair, V. , Fischer, E. R. , Barker, J. R. , Klose, K. E. , & Celli, J. (2008). The early phagosomal stage of Francisella tularensis determines optimal phagosomal escape and Francisella pathogenicity island protein expression. Infection and Immunity, 76, 5488–5499. 10.1128/IAI.00682-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cianfanelli, F. R. , Monlezun, L. , & Coulthurst, S. J. (2016). Aim, load, fire: The type VI secretion system, a bacterial nanoweapon. Trends in Microbiology, 24, 51–62. 10.1016/j.tim.2015.10.005 [DOI] [PubMed] [Google Scholar]
  14. Clemens, D. L. , Ge, P. , Lee, B. Y. , Horwitz, M. A. , & Zhou, Z. H. (2015). Atomic structure of T6SS reveals interlaced array essential to function. Cell, 160, 940–951. 10.1016/j.cell.2015.02.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Clemens, D. L. , Lee, B. Y. , & Horwitz, M. A. (2004). Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages. Infection and Immunity, 72, 3204–3217. 10.1128/IAI.72.6.3204-3217.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Clemens, D. L. , Lee, B. Y. , & Horwitz, M. A. (2005). Francisella tularensis enters macrophages via a novel process involving pseudopod loops. Infection and Immunity, 73, 5892–5902. 10.1128/IAI.73.9.5892-5902.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Conduit, P. T. , Wainman, A. , & Raff, J. W. (2015). Centrosome function and assembly in animal cells. Nature Reviews Molecular Cell Biology, 16, 611–624. 10.1038/nrm4062 [DOI] [PubMed] [Google Scholar]
  18. Decors, A. , Lesage, C. , Jourdain, E. , Giraud, P. , Houbron, P. , Vanhem, P. , & Madani, N. (2011). Outbreak of tularaemia in brown hares (Lepus europaeus) in France, January to March 2011. Eurosurveillance, 16, 19913. [PubMed] [Google Scholar]
  19. Desvaux, M. , Hébraud, M. , Talon, R. , & Henderson, I. R. (2009). Secretion and subcellular localizations of bacterial proteins: A semantic awareness issue. Trends in Microbiology, 17, 139–145. 10.1016/j.tim.2009.01.004 [DOI] [PubMed] [Google Scholar]
  20. Dumoux, M. , Menny, A. , Delacour, D. , & Hayward, R. D. (2015). A Chlamydia effector recruits CEP170 to reprogram host microtubule organization. Journal of Cell Science, 128, 3420–3434. 10.1242/jcs.169318 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ellis, J. , Oyston, P. C. , Green, M. , & Titball, R. W. (2002). Tularemia. Clinical Microbiology Reviews, 15, 631–646. 10.1128/CMR.15.4.631-646.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Eshraghi, A. , Kim, J. , Walls, A. C. , Ledvina, H. E. , Miller, C. N. , Ramsey, K. M. , … Mougous, J. D. (2016). Secreted effectors encoded within and outside of the Francisella Pathogenicity Island promote intramacrophage growth. Cell Host & Microbe, 20, 573–583. 10.1016/j.chom.2016.10.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Golovliov, I. , Baranov, V. , Krocova, Z. , Kovarova, H. , & Sjöstedt, A. (2003). An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells. Infection and Immunity, 71, 5940–5950. 10.1128/IAI.71.10.5940-5950.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hachani, A. , Wood, T. E. , & Filloux, A. (2016). Type VI secretion and anti‐host effectors. Current Opinion in Microbiology, 29, 81–93. 10.1016/j.mib.2015.11.006 [DOI] [PubMed] [Google Scholar]
  25. Harrison, R. E. , Bucci, C. , Vieira, O. V. , Schroer, T. A. , & Grinstein, S. (2003). Phagosomes fuse with late endosomes and/or lysosomes by extension of membrane protrusions along microtubules: Role of Rab7 and RILP. Molecular and Cellular Biology, 23, 6494–6506. 10.1128/MCB.23.18.6494-6506.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ho, B. T. , Dong, T. G. , & Mekalanos, J. J. (2014). A view to a kill: The bacterial type VI secretion system. Cell Host & Microbe, 15, 9–21. 10.1016/j.chom.2013.11.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kimura, S. , Noda, T. , & Yoshimori, T. (2008). Dynein‐dependent movement of autophagosomes mediates efficient encounters with lysosomes. Cell Structure and Function, 33, 109–122. 10.1247/csf.08005 [DOI] [PubMed] [Google Scholar]
  28. Kingry, L. C. , & Petersen, J. M. (2014). Comparative review of Francisella tularensis and Francisella novicida . Frontiers in Cellular and Infection Microbiology, 4, 35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lertpiriyapong, K. , Gamazon, E. R. , Feng, Y. , Park, D. S. , Pang, J. , Botka, G. , … Fox, J. G. (2012). Campylobacter jejuni type VI secretion system: Roles in adaptation to deoxycholic acid, host cell adherence, invasion, and in vivo colonization. PLoS ONE, 7, e42842 10.1371/journal.pone.0042842 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mattoo, S. , Lee, Y. M. , & Dixon, J. E. (2007). Interactions of bacterial effector proteins with host proteins. Current Opinion in Immunology, 19, 392–401. 10.1016/j.coi.2007.06.005 [DOI] [PubMed] [Google Scholar]
  31. Maurin, M. (2015). Francisella tularensis as a potential agent of bioterrorism? Expert Review of Anti‐Infective Therapy, 13, 141–144. 10.1586/14787210.2015.986463 [DOI] [PubMed] [Google Scholar]
  32. Mc Gann, P. , Rozak, D. A. , Nikolich, M. P. , Bowden, R. A. , Lindler, L. E. , Wolcott, M. J. , & Lathigra, R. (2010). A novel brain heart infusion broth supports the study of common Francisella tularensis serotypes. Journal of Microbiol Methods, 80, 164–171. 10.1016/j.mimet.2009.12.005 [DOI] [PubMed] [Google Scholar]
  33. Merriam, J. J. , Mathur, R. , Maxfield‐Boumil, R. , & Isberg, R. R. (1997). Analysis of the Legionella pneumophila fliI gene: Intracellular growth of a defined mutant defective for flagellum biosynthesis. Infection and Immunity, 65, 2497–2501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Miller, W. G. , & Lindow, S. E. (1997). An improved GFP cloning cassette designed for prokaryotic transcriptional fusions. Gene, 191, 149–153. 10.1016/S0378-1119(97)00051-6 [DOI] [PubMed] [Google Scholar]
  35. Mougous, J. D. , Cuff, M. E. , Raunser, S. , Shen, A. , Zhou, M. , Gifford, C. A. , … Mekalanos, J. J. (2006). A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. Science, 312, 1526–1530. 10.1126/science.1128393 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Müller, P. , Chikkaballi, D. , & Hensel, M. (2012). Functional dissection of SseF, a membrane‐integral effector protein of intracellular Salmonella enterica . PLoS ONE, 7, e35004 10.1371/journal.pone.0035004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Nagle, S. C., Jr. , Anderson, R. E. , & Gary, N. D. (1960). Chemically defined medium for the growth of Pasteurella tularensis . Journal of Bacteriology, 79, 566–571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Nakayama, K. (2015). Porphyromonas gingivalis and related bacteria: From colonial pigmentation to the type IX secretion system and gliding motility. Journal of Periodontal Research, 50, 1–8. 10.1111/jre.12255 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Nano, F. E. , Zhang, N. , Cowley, S. C. , Klose, K. E. , Cheung, K. K. , Roberts, M. J. , … Elkins, K. L. (2004). A Francisella tularensis pathogenicity island required for intramacrophage growth. Journal of Bacteriology, 186, 6430–6436. 10.1128/JB.186.19.6430-6436.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Nguyen, J. Q. , Gilley, R. P. , Zogaj, X. , Rodriguez, S. A. , & Klose, K. E. (2014). Lipidation of the FPI protein IglE contributes to Francisella tularensis ssp. novicida intramacrophage replication and virulence. Pathogens and Disease, 72, 10–18. 10.1111/2049-632X.12167 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Pavlov, V. M. , Mokrievich, A. N. , & Volkovoy, K. (1996). Cryptic plasmid pFNL10 from Francisella novicida‐like F6168: The base of plasmid vectors for Francisella tularensis . FEMS Immunology and Medical Microbiology, 13, 253–256. 10.1111/j.1574-695X.1996.tb00247.x [DOI] [PubMed] [Google Scholar]
  42. Petersen, J. M. , Mead, P. S. , & Schriefer, M. E. (2009). Francisella tularensis: An arthropod‐borne pathogen. Veterinary Research, 40, 7 10.1051/vetres:2008045 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Pomerantsev, A. P. , Obuchi, M. , & Ohara, Y. (2001). Nucleotide sequence, structural organization, and functional characterization of the small recombinant plasmid pOM1 that is specific for Francisella tularensis . Plasmid, 46, 86–94. 10.1006/plas.2001.1538 [DOI] [PubMed] [Google Scholar]
  44. Pukatzki, S. , Ma, A. T. , Sturtevant, D. , Krastins, B. , Sarracino, D. , Nelson, W. C. , … Mekalanos, J. J. (2006). Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proceedings of the National Academy of Sciences of the United States of America, 103, 1528–1533. 10.1073/pnas.0510322103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Robertson, G. T. , Child, R. , Ingle, C. , Celli, J. , & Norgard, M. V. (2013). IglE is an outer membrane‐associated lipoprotein essential for intracellular survival and murine virulence of type A Francisella tularensis . Infection and Immunity, 81, 4026–4040. 10.1128/IAI.00595-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Rodriguez, S. A. , Yu, J. J. , Davis, G. , Arulanandam, B. P. , & Klose, K. E. (2008). Targeted inactivation of Francisella tularensis genes by group II introns. Applied and Environment Microbiology, 74, 2619–2626. 10.1128/AEM.02905-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Sana, T. G. , Baumann, C. , Merdes, A. , Soscia, C. , Rattei, T. , Hachani, A. , … Bleves, S. (2015). Internalization of Pseudomonas aeruginosa strain PAO1 into epithelial cells is promoted by interaction of a T6SS effector with the microtubule network. MBio, 6, e00712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Schwarz, S. , West, T. E. , Boyer, F. , Chiang, W. C. , Carl, M. A. , Hood, R. D. , … Mougous, J. D. (2010). Burkholderia type VI secretion systems have distinct roles in eukaryotic and bacterial cell interactions. PLoS Pathogens, 6, e1001068 10.1371/journal.ppat.1001068 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Suzuki, J. , Hashino, M. , Matsumoto, S. , Takano, A. , Kawabata, H. , Takada, N. , … Watarai, M. (2016). Detection of Francisella tularensis and analysis of bacterial growth in ticks in Japan. Letters in Applied Microbiology, 63, 240–246. 10.1111/lam.12616 [DOI] [PubMed] [Google Scholar]
  50. Suzuki, J. , Uda, A. , Watanabe, K. , Shimizu, T. , & Watarai, M. (2016). Symbiosis with Francisella tularensis provides resistance to pathogens in the silkworm. Scientific Reports, 6, 31476 10.1038/srep31476 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Uda, A. , Sekizuka, T. , Tanabayashi, K. , Fujita, O. , Kuroda, M. , Hotta, A. , … Yamada, A. (2014). Role of pathogenicity determinant protein C (PdpC) in determining the virulence of the Francisella tularensis subspecies tularensis SCHU. PLoS ONE, 9, e89075 10.1371/journal.pone.0089075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Yoshino, K. , Oshiro, N. , Tokunaga, C. , & Yonezawa, K. (2004). Mass spectrometry‐based protein identification by correlation with sequence database. Journal of the Mass Spectrometry Society of Japan, 52, 106–129. 10.5702/massspec.52.106 [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

 


Articles from MicrobiologyOpen are provided here courtesy of Wiley

RESOURCES